1
|
Imano N, Kawahara D, Nishioka R, Koike K, Katsuta T, Hirokawa J, Saito A, Nishibuchi I, Murakami Y, Nagata Y. Predictive Modeling of Radiation Pneumonitis Induced by Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer Using Radiomics and Clinical Features. Int J Radiat Oncol Biol Phys 2023; 117:e26. [PMID: 37784995 DOI: 10.1016/j.ijrobp.2023.06.704] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) The purpose of this study is to establish a prediction model for the development of grade 2 or higher radiation pneumonitis (RP) using radiomics analysis of pretreatment CT images, PET images, and dose distribution, in addition to clinical factors, in patients with locally advanced non-small cell lung cancer (NSCLC) treated with radical chemoradiotherapy. MATERIALS/METHODS We retrospectively evaluated 128 cases of locally advanced NSCLC treated with radical radiotherapy at our institution from 2008 to 2021. Clinical factors included age, sex, performance status (PS), KL-6, smoking history, histological type, clinical stage, and total radiation dose. Radiomics analysis was performed by analyzing treatment planning CT images, PET images, and dose distribution, and Rad-score (Radiomics-score) was calculated for the extracted features using Lasso-Cox regression. Rad-score (Radiomics-score) was calculated by Lasso-Cox regression for the extracted features. Risk factors were selected by univariate/multivariate analysis of clinical factors and Rad-score. Three models for predicting RP were developed from the identified risk factors using Nomogram: Clinical, Rad-score, and Combined model. The model was evaluated using area under the curve (AUC) based on receiver operating characteristic (ROC) curves and concordance index (C-index). RP was evaluated using the Common Terminology Criteria for Adverse Events (CTCAE) version 5.0. The cumulative incidence of Grade 2 or higher RP was evaluated using the Kaplan-Meier method. RESULTS Of the 128 cases, grade 2 or higher RP was observed in 50 cases (39%). Regarding clinical factors, gender, smoking status, and histology were selected as significant predictors of RP. Lasso-Cox analysis of radiomics features selected 11 features from CT images, 7 features from PET images, and 16 features from dose distribution as predictors of RP, yielding a total of 34 factors. The combined model (C-index: 0.96, AUC: 0.92) showed the best discrimination performance compared to the clinical model (C-index: 0.73, AUC: 0.56) and the Rad-score model (C-index: 0.87, AUC: 0.92). Risk classification using the combined model showed that the 1-year cumulative incidence of grade 2 or higher RP was 65% in the high-risk group, significantly higher than 15% in the low-risk group (p<0.001). CONCLUSION The combined model with Rad-score and clinical factors can predict grade 2 or higher RP in NSCLC patients with high accuracy.
Collapse
Affiliation(s)
- N Imano
- Department of Radiation Oncology, Graduate School of Biomedical Health Sciences, Hiroshima University, Hiroshima, Japan
| | - D Kawahara
- Department of Radiation Oncology, Hiroshima University Hospital, Hiroshima, Japan
| | - R Nishioka
- Department of Radiation Oncology, Graduate School of Biomedical Health Sciences, Hiroshima University, Hiroshima, Japan
| | - K Koike
- Department of Radiation Oncology, Graduate School of Biomedical Health Sciences, Hiroshima University, Hiroshima, Japan
| | - T Katsuta
- Department of Radiation Oncology, Hiroshima University Hospital, Hiroshima, Japan
| | - J Hirokawa
- Department of Radiation Oncology, Hiroshima University Hospital, Hiroshima, Japan
| | - A Saito
- Department of Radiation Oncology, Hiroshima University Hospital, Hiroshima, Japan
| | - I Nishibuchi
- Department of Radiation Oncology, Hiroshima University Hospital, Hiroshima, Japan
| | - Y Murakami
- Department of Radiation Oncology, Graduate School of Biomedical Health Sciences, Hiroshima University, Hiroshima, Japan
| | - Y Nagata
- Department of Radiation Oncology, Graduate School of Biomedical Health Sciences, Hiroshima University, Hiroshima, Japan
| |
Collapse
|
2
|
Shinde T, Saito A, Okada K, Wakasa M, Kimoto M, Kamada T, Shibata K, Okura K, Sato H, Takahashi Y. Influence of lower extremity rotation on knee kinematics in single-leg landing. Phys Ther Sport 2022; 58:87-92. [DOI: 10.1016/j.ptsp.2022.10.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2022] [Revised: 10/02/2022] [Accepted: 10/03/2022] [Indexed: 11/29/2022]
|
3
|
Matsumura T, Hashimoto H, Sekimizu M, Saito A, Asakura M, Kimura K, Iwata Y. VP.59 A single-arm, open-label, multicenter study of tranilast for advanced heart failure in patients with muscular dystrophy. Neuromuscul Disord 2022. [DOI: 10.1016/j.nmd.2022.07.253] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
4
|
Shimoi T, Saito A, Charvat H, Matsuda T, Yonemori K. 1523P Incidence and geographic distribution of bone and soft tissue sarcoma in Japan using a nationwide population-based analysis: 69,734 cases. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.1912] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
5
|
Imano N, Kimura T, Kawahara D, Kubo K, Takeuchi Y, Saito A, Nishibuchi I, Murakami Y, Nagata Y. Potential Benefits of Volumetric Modulated Arc Therapy to Reduce the Incidence of Grade 2 Radiation Pneumonitis in Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer Patients. Int J Radiat Oncol Biol Phys 2021. [DOI: 10.1016/j.ijrobp.2021.07.1244] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
6
|
Kishikawa R, Hatano M, Ishii S, Shimbo M, Saito A, Minatsuki S, Iwasaki Y, Fujio K, Komuro I. AB0285 EFFECTIVENESS OF IMMUNOSUPPRESSIVE THERAPY FOR CONNECTIVE TISSUE DISEASE–ASSOCIATED PULMONARY ARTERIAL HYPERTENSION. Ann Rheum Dis 2021. [DOI: 10.1136/annrheumdis-2021-eular.1573] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Background:Connective tissue disease (CTD) associated pulmonary arterial hypertension (PAH) is considered to be an indication for immunosuppressive therapy (IT) except scleroderma associated PAH. However, the response rate defined by improvement of WHO functional class and hemodynamic parameters is reported to be around 50% [1]. Since CTDs are systemic diseases, it may be difficult to evaluate the efficacy of IT by subjective symptoms. Although there are previous studies reporting that the combined use of IT and pulmonary vasodilators significantly improved hemodynamics [2], response to IT without titration of pulmonary vasodilators remains to be elucidated.Objectives:To examine whether IT is effective for CTD-PAH.Methods:We retrospectively examined the medical records of consecutive 13 patients with CTD-PAH (female 13, mean age 47 ± 15 years) treated with methylprednisolone (1 mg/kg/day, oral) and intravenous bolus cyclophosphamide (IVCY) (500 mg/m2) every four weeks for six times. Patient characteristics are described in Table 1. Right heart catheterization (RHC) was done at prior to IT, before adding PAH specific agents, and at the fifth or sixth course of IVCY. In treated cases, the previous vasodilators remained unchanged during the first term of IT.Results:At the first follow up RHC, decrease of mean pulmonary arterial pressure over 5 mmHg was observed in all patients, and decrease of pulmonary vascular resistance (PVR) was observed in twelve out of 13 patients (Figure 1). Over 20% of PVR reduction was observed more in the patients of pulmonary vasodilator naïve and started IT within one year from symptoms than others (6/7 vs 1/6, p=0.03). Although six-minutes walk distance (6MWD) tended to be prolonged between first and second RHC (298 ± 70 m vs 382 ± 81 m; p=0.054; n = 9), 6MWD was shortened in some cases with good hemodynamic improvement (2/5). All patients were prescribed oral PAH specific agents finally, but no one needed parenteral prostanoids. Two patients (15%) died during maintenance therapy for causes other than PAH. Three-year and five-year survival rates were 91.7% and 81.5%, respectively.Conclusion:IT without titration of pulmonary vasodilators significantly improved hemodynamic parameters despite of less improvement in 6MWD in CTD-PAH patients. Considering that CTDs itself might affect the exercise tolerance regardless of PAH, these hemodynamic changes may contribute to better prognosis and IT might be considered especially for patients early in clinical courses and treatment naïve.References:[1]Jais X, Launay D, Yaici A, et al. Immunosupressive therapy in lupus-and mixed connective tissue disease-associated pulmonary arterial hypertension. ARTHRITIS RHEUM. 2008; 58(2): 521-531.[2]Yamamoto M S, Fukumoto Y, Sugimura K, et al. Intensive immunosuppressive therapy improves pulmonary hemodynamics and long-term prognosis in patients with pulmonary arterial hypertension associated with connective tissue diseasae. Circ J. 2011; 75: 2668-2674.Table 1.Characteristics of patientsPatientAge,yrConnective Tissue DiseaseYears from symptom to immunosuppressive therapyPrevious vasodilatorsvasodilators at final visit147SS1.5PGI2ERA262SS, RA2nonePDE5332SS1noneERA457SS, SSc0.5nonePDE5526SS,MCTD, SLE,SSc0.5nonePDE5670SSc, SS s/o13sGC, ERAsGC, ERA732SS s/o, SLE0.1nonePDE5831MCTD3ERA,PDE5, PGI2ERA,PDE5, PGI2943SSc, SLE0.6ERA, PDE5ERA,PDE5, PGI21067MCTD,PM0nonesGC1141SS0.1noneERA, PDE51269SS0.3nonePDE51344SS, MCTD s/o, SLE s/o0.1noneERA, sGCN.A, not acquired; s/o, suspect of; SS, Sjögren’s syndrome; RA, rheumatoid arthritis; SSc systemic sclerosis; SLE, systemic lupus erythematosus; MCTD, mixed connective tissue disease; PM, Polymyositis; PGI2, prostacyclin derivative; sGC, soluble guanylate cyclase stimulator; ERA, endothelin receptor antagonist; PDE5, phosphodiesterase type 5 inhibitor.Figure 1.Hemodynamic changes during immunosuppressive therapyDisclosure of Interests:Risa Kishikawa: None declared, Masaru Hatano Speakers bureau: Janssen Pharmaceutical K.K, Bayer Yakuhin, Ltd., Grant/research support from: Janssen Pharmaceutical K.K, Nippon Shinyaku Co., Ltd., MOCHIDA PHARMACEUTICAL CO., LTD., Satoshi Ishii: None declared, Mai Shimbo: None declared, Akihito Saito: None declared, Shun Minatsuki: None declared, Yukiko Iwasaki: None declared, Keishi Fujio Speakers bureau: Tanabe Mitsubishi, Bristol Myers, Eli Lilly, Chugai, Jansen, Pfizer, Ono, AbbVie, Ayumi, Astellas, Sanofi, Novartis, Daiichi Sankyo, Eisai, Asahi Kasei, Japan Blood Products Organization, and Kowa, Grant/research support from: Tanabe Mitsubishi, Bristol Myers, Eli Lilly, Chugai, AbbVie, Ayumi, Astellas, Sanofi, Eisai, Tsumura & Co., and Asahi Kasei., Issei Komuro Speakers bureau: AstraZeneka, Daiichi Sankyo Company, Limited, Takeda Pharmaceutical Company Limited, Bayer Yakuhin, Ltd, Pfizer Japan Inc., and Ono Pharmaceutical Co., Ltd., Grant/research support from: Daiichi Sankyo Company, Ltd, Sumitomo Dainippon Pharma Co., Ltd., Takeda Pharmaceutical Company Ltd, Mitsubishi Tanabe Pharma Corporation, Teijin Pharma Limited, Idorsia Pharmaceuticals Ltd, Otsuka Pharmaceutical Co., Ltd., Bayer Yakuhin, Ltd. Ono Pharmaceutical Co., Ltd. Toa Eiyo Ltd
Collapse
|
7
|
Ote K, Hashimoto F, Kakimoto A, Isobe T, Inubushi T, Ota R, Tokui A, Saito A, Moriya T, Omura T, Yoshikawa E, Teramoto A, Ouchi Y. Kinetics-Induced Block Matching and 5-D Transform Domain Filtering for Dynamic PET Image Denoising. IEEE Trans Radiat Plasma Med Sci 2020. [DOI: 10.1109/trpms.2020.3000221] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
8
|
Takeuchi Y, Kameoka T, Ochi M, Imano N, Takahashi I, Nishibuchi I, Kimura T, Murakami Y, Kawahara D, Miki K, Saito A, Nagata Y. Interstitial Brachytherapy For Locally Advanced Tongue Cancer: Analysis Of The Long-Term Treatment Results For Survival And Complications. Int J Radiat Oncol Biol Phys 2020. [DOI: 10.1016/j.ijrobp.2020.07.297] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
9
|
Obata Y, Ishimori N, Saito A, Kinugawa S, Nakano I, Kakutani N, Yamanashi K, Yokota T, Anzai T. Activation of invariant natural killer T cells ameliorates doxorubicin-induced cardiotoxicity in mice. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.3710] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Objective
Doxorubicin (DOX) is one of the most important anticancer agents and widely used to treat cancers but clinical utility of DOX is limited for its dose-dependent cardiotoxicity. The precise mechanism of DOX-induced cardiotoxicity is still not fully understood but it has been reported that cardiac inflammation is involved in the cardiotoxicity. Invariant natural killer T (iNKT) cells, a unique subset of T lymphocytes that recognize glycolipid antigens and secrete a large amount of both Th1 and Th2 cytokines on activation, have been shown to play crucial roles in the regulation of immune responses. However, it remains unclear whether iNKT cells are involved in DOX-induced cardiotoxicity.
Methods and results
Male C57BL/6J mice were administered DOX (20mg/kg body weight; n=28) or vehicle (Vehicle; n=6). DOX-administered mice were further divided into 2 groups; those treated with α-galactosylceramide (αGC, 0.1μg/g body weight; DOX-αGC; n=14), which specifically activates iNKT cells, or those treated with PBS (DOX-PBS; n=14) by intraperitoneal injections (twice; 4 days before and 3 days after DOX administration).An echocardiography conducted at 14 days after DOX/Vehicle administration revealed that LV fractional shortening was significantly reduced in the DOX-PBS compared to the Vehicle (49.3±0.8% vs. 59.2±1.7%, P<0.05), and this decrease was completely attenuated in the DOX-αGC (57.7±1.3%, P<0.05 vs. DOX-PBS)without affecting LV end-diastolic diameter. Flow cytometric analysis revealed that the ratio of iNKT cells to mononuclear cells infiltrated into the heart tissue was significantly increased in the DOX+αGC compared to the Vehicle and the DOX+PBS (1.00±0.09% vs. 0.54±0.09% and 0.71±0.07%, P<0.05). Immuno-histochemistry revealed that the infiltration number of Iba1+macrophages in the heart tissue was significantly elevated in the DOX+αGC compared to the Vehicle and the DOX+PBS (55.4±3.2 cells/mm2 vs. 21.7±2.0 cells/mm2 and 37.5±5.9 cells/mm2, P<0.05) The ratio of fibrosis area to the heart tissue was markedly higher in the DOX-PBS than in Vehicle (4.3±0.5% vs. 2.2±0.1%, P<0.05), and this increase was completely attenuated in the DOX-αGC (2.8±0.1%, P<0.05 vs.DOX-PBS).Real-time PCR analysis revealed that mRNA expressions of M2 macrophage markers (Arginase 1 and Retnla) and IL-4 were significantly enhanced in the DOX+αGC compared to the DOX+PBS (Arginase 1: 2.5±0.4 vs. 1.6±0.3 [relative ratio to the Vehicle], P=0.08; Retnla: 2.4±0.5 vs. 1.1±0.2 [relative ratio to the Vehicle], P<0.05; IL-4: 1.0±0.3 vs. 8.94±2.8 [relative ratio to the DOX+PBS], P<0.05), while those of M1 macrophage markers (iNOS and MCP-1) did not change among all groups.
Conclusions
Activation of iNKT cells ameliorates DOX-induced cardiotoxicity in mice via enhanced M2 macrophage polarization with the upregulation of IL-4 and reducing cardiac fibrosis. iNKT cell activation can be a novel preventive strategy against DOX-induced cardiotoxicity.
Funding Acknowledgement
Type of funding source: Foundation. Main funding source(s): Japan Agency for Medical Research and Development (18lm0203001j0002) and JSPS KAKENHI (18K15834).
Collapse
Affiliation(s)
- Y Obata
- Hokkaido University, Cardiovascular Medicine, Sapporo, Japan
| | - N Ishimori
- Hokkaido University, Cardiovascular Medicine, Sapporo, Japan
| | - A Saito
- Health Sciences University of Hokkaido, Cardiovascular Medicine, Sapporo, Japan
| | - S Kinugawa
- Hokkaido University, Cardiovascular Medicine, Sapporo, Japan
| | - I Nakano
- Hokkaido University, Cardiovascular Medicine, Sapporo, Japan
| | - N Kakutani
- Hokkaido University, Cardiovascular Medicine, Sapporo, Japan
| | - K Yamanashi
- Hokkaido University, Cardiovascular Medicine, Sapporo, Japan
| | - T Yokota
- Hokkaido University, Sapporo, Japan
| | - T Anzai
- Hokkaido University, Cardiovascular Medicine, Sapporo, Japan
| |
Collapse
|
10
|
Minatsuki S, Kiyosue A, Kodera S, Saito A, Maki H, Hatano M, Takimoto E, Ando J, Komuro I. Novel procedural method for balloon pulmonary angioplasty to treat chronic thromboembolic pulmonary hypertension. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.2264] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
The current strategy of balloon pulmonary angioplasty (BPA) for chronic thromboembolic pulmonary hypertension (CTEPH) is to dilate branches as many as possible without lung injury to normalize mean pulmonary artery pressure and oxygenation. The shape of guiding catheter is one of the important factors to achieve this strategy. However, conventional guiding catheters which are typically used for BPA are difficult to introduce into particular branches. The Ikari-curve left (IL) guiding catheter may be suitable for this purpose by adjusting its curves (Figure 1); however, its utility and effectiveness for lung injury are unclear.
Purpose
The aim of this study is to clarify utility and safety of IL guiding catheter for BPA.
Methods
We retrospectively analyzed 202 consecutive BPA sessions of 40 patients with CTEPH from November 2016 to October 2019 and divided them into two groups; IL group, in which we used IL guiding catheter; and non-IL group in which we used others. IL guiding catheter was used for branches of left lung which are difficult to introduce by conventional catheter prior Nov. 2018. After Nov.2018, we also used it for the same type branches of right lung. The occurrence of lung injury was determined by the presence of bloody sputum during the perioperative period. We compared success rate of introduction into target vessels and of occurrence of lung injury.
Results
The average age of enrolled patients was 60.3±14.4 year-old and female was 65%. There were 99 sessions in IL group. The median treated branches significantly differed between groups (IL group: 15 vs. non-IL group: 10, p<0.05). The lung injury rate tended to low in the IL group (4.0% vs. 11.7%, p=0.07). The IL group had more successful insertions into branches than did the non-IL group (right lung: middle lobe*, 84.4% vs. 57.5%; medial basal branch*, 46.9% vs. 7.5%; left lung: anterior ascending and descending branches, 82.9% vs. 70.8%; lingular branches*, 90.0% vs. 62.5%; anterior basal branch, 75.7% vs. 62.5%, * p<0.05).
Conclusion
IL guiding catheter can be introduced into branches that cannot be accessed via conventional guiding catheters and has potential to reduce the occurrence of lung injury. 2228 characters including space
Figure1
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
| | - A Kiyosue
- The University of Tokyo, Tokyo, Japan
| | - S Kodera
- The University of Tokyo, Tokyo, Japan
| | - A Saito
- The University of Tokyo, Tokyo, Japan
| | - H Maki
- The University of Tokyo, Tokyo, Japan
| | - M Hatano
- The University of Tokyo, Tokyo, Japan
| | | | - J Ando
- The University of Tokyo, Tokyo, Japan
| | - I Komuro
- The University of Tokyo, Tokyo, Japan
| |
Collapse
|
11
|
Asano T, Ono M, Saito A, Kanie T, Takaoka T, Komiyama N. Twenty-year trends in clinical outcome of randomized controlled trial for coronary intervention: systematic review and meta-regression analysis of 46 randomized controlled trials. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.1473] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Aim
The technology of percutaneous coronary intervention (PCI) has been developed after the advent of coronary stent. However, the impact of the technological development on clinical outcomes is still unclear, whereas a remarkable improvement of clinical outcomes after PCI has not been observed in the trials comparing to medical therapy or coronary bypass graft. The current analysis aims to investigate trends in clinical outcomes after PCI after the emargence of coronary stent, using the randomized controlled trials (RCTs) comparing coronary stents.
Methods and results
We performed a systematic review of RCTs investigating coronary stents in non-specific population (excluding the trials particularly enrolling diabetic or myocardial infarction etc.) conducted between 1996 and 2015 (publication between 1997 and 2019) with independent clinical event adjudication. The random-effect meta-regression analysis including 90 arms with 94,831 patients in 46 RCTs was performed investigating the 20-year trends in clinical outcomes such as death, cardiac death, myocardial infarction, target lesion revascularization (TLR) and stent thrombosis at one and five years after the index procedure. The sensitivity analysis was performed by limiting to 20 all comer trials. In the meta-regression analysis, we did not observe significant change in the incidences of cardiac death and myocardial infarction after PCI over 20 years (P values for cardiac death: 0.666 at one year, 0.256 at five years and P values for myocardial infarction: 0.121 at one year, 0.376 at five years; R2 for cardiac death: <0.01 at one year and five years and R2 for myocardial infarction: <0.01 at one year and five years), whereas the incidences of clinically indicated TLR (P value <0.001, R2 = 0.40 at one year, P value = 0.002, R2 = 0.22 at five years) and stent thrombosis were decreased steeply in the first decade and slightly in the second decade (P value = 0.040, R2 = 0.09 at one year; P value = 0.017, R2 = 0.17 at five year). The sencitivity analysis limiting all-comer population revealed the consistent results.
Conclusion
The development of PCI had an impact on the 20-year trends in TLR and ST, despite there were no trends in the cardiac death and myocardial infarction.
Trends in the incidence of the outcomes
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
- T Asano
- St. Luke's International Hospital, Cardiology, Tokyo, Japan
| | - M Ono
- St. Luke's International Hospital, Cardiology, Tokyo, Japan
| | - A Saito
- St. Luke's International Hospital, Cardiology, Tokyo, Japan
| | - T Kanie
- St. Luke's International Hospital, Cardiology, Tokyo, Japan
| | - T Takaoka
- St. Luke's International Hospital, Cardiology, Tokyo, Japan
| | - N Komiyama
- St. Luke's International Hospital, Cardiology, Tokyo, Japan
| |
Collapse
|
12
|
Okiyama N, Nakamura Y, Ishitsuka Y, Inoue S, Kubota N, Saito A, Watanabe R, Fujisawa Y, Igawa K. Successful topical treatment with ketoconazole for facial rashes refractory to dupilumab in patients with atopic dermatitis: case reports. J Eur Acad Dermatol Venereol 2020; 34:e474-e476. [DOI: 10.1111/jdv.16383] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2020] [Revised: 02/29/2020] [Accepted: 03/16/2020] [Indexed: 12/20/2022]
Affiliation(s)
- N. Okiyama
- Department of Dermatology Faculty of Medicine University of Tsukuba Ibaraki Japan
| | - Y. Nakamura
- Department of Dermatology Faculty of Medicine University of Tsukuba Ibaraki Japan
| | - Y. Ishitsuka
- Department of Dermatology Faculty of Medicine University of Tsukuba Ibaraki Japan
| | - S. Inoue
- Department of Dermatology Faculty of Medicine University of Tsukuba Ibaraki Japan
| | - N. Kubota
- Department of Dermatology Faculty of Medicine University of Tsukuba Ibaraki Japan
| | - A. Saito
- Department of Dermatology Faculty of Medicine University of Tsukuba Ibaraki Japan
| | - R. Watanabe
- Department of Dermatology Faculty of Medicine University of Tsukuba Ibaraki Japan
| | - Y. Fujisawa
- Department of Dermatology Faculty of Medicine University of Tsukuba Ibaraki Japan
| | - K. Igawa
- Department of Dermatology Dokkyo Medical University School of Medicine Tochigi Japan
| |
Collapse
|
13
|
Silbernagel KM, Lindberg KG, Ary M, Bannach B, Barbour M, Battista K, Bauten H, Beatty S, Bogar S, Buczek L, Bulthau M, Burnett T, Carver C, Cha K, Cooper L, D’Andrea L, Davis B, Fain A, Feiler B, Fender M, Hirt W, Iannucci M, Jackson JK, Jensen D, Johnson K, Julien-Davis G, Kempf A, Krone P, Kusch S, LaPointe A, Leiva BR, Lewandowski V, Lewis J, Maycock L, Mebs D, McCann T, Moulsoff M, Newcomer C, Ooya M, O’Shea P, Otten N, Reed J, Remes A, Resutek J, Rukamp B, Rukamp S, Saito A, Shafie A, Smith A, Tabatt J, Tanaka H, Torrance H, VandeVoort M, Wang D, Windsor S, Xiong Y, Zebchuck A. Petrifilm™ Rapid S. aureus Count Plate Method for Rapid Enumeration of Staphylococcus aureus in Selected Foods: Collaborative Study. J AOAC Int 2019. [DOI: 10.1093/jaoac/84.5.1431] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Abstract
A rehydratable dry-film plating method for Staphylococcus aureusin foods, the 3M™ Petrifilm™ Rapid S. aureus Count Plate method, was compared with AOAC® Official MethodSM 975.55 (Staphylococcus aureus in Foods). Nine foods—instant nonfat dried milk, dry seasoned vegetable coating, frozen hash browns, frozen cooked chicken patty, frozen ground raw pork, shredded cheddar cheese, fresh green beans, pasta filled with beef and cheese, and egg custard—were analyzed for S. aureus by 13 collaborating laboratories. For each food tested, the collaborators received 8 blind test samples consisting of a control sample and 3 levels of inoculated test sample, each in duplicate. The mean log counts for the methods were comparable for pasta filled with beef and cheese; frozen hash browns; cooked chicken patty; egg custard; frozen ground raw pork; and instant nonfat dried milk. The repeatability and reproducibility variances of the Petrifilm Rapid S. aureus Count Plate method were similar to those of the standard method.
Collapse
|
14
|
Nakamura Y, Ishitsuka Y, Tanaka R, Okiyama N, Saito A, Watanabe R, Fujisawa Y. Acral lentiginous melanoma and mucosal melanoma expressed less programmed-death 1 ligand than cutaneous melanoma: a retrospective study of 73 Japanese melanoma patients. J Eur Acad Dermatol Venereol 2019; 33:e424-e426. [PMID: 31187906 DOI: 10.1111/jdv.15742] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2019] [Revised: 05/10/2019] [Accepted: 05/29/2019] [Indexed: 12/30/2022]
Affiliation(s)
- Y Nakamura
- Department of Dermatology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan
| | - Y Ishitsuka
- Department of Dermatology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan
| | - R Tanaka
- Department of Dermatology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan
| | - N Okiyama
- Department of Dermatology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan
| | - A Saito
- Department of Dermatology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan
| | - R Watanabe
- Department of Dermatology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan
| | - Y Fujisawa
- Department of Dermatology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan
| |
Collapse
|
15
|
Obata Y, Ishimori N, Saito A, Kinugawa S, Nakano I, Kakutani N, Yamanashi K, Anzai T. P1623Activation of invariant natural killer T cells by alpha-galactosylceramide ameliorates doxorubicin-induced cardiotoxicity in mice. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz748.0382] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Objective
Doxorubicin (DOX) is an effective antineoplastic agent commonly used to treat many types of cancer but its clinical use is limited because of cardiotoxicity, which might proceed to irreversible cardiac dysfunction in a dose-dependent manner. The precise mechanism of DOX-induced cardiotoxicity is still not fully elucidated but it has been reported that cardiac inflammation is involved in the cardiotoxicity. Invariant natural killer T (iNKT) cells, a unique subset of T lymphocytes that recognize glycolipid antigens and secrete a large amount of Th1 and Th2 cytokines on activation, have been shown to play crucial roles in the regulation of immune responses. However, it remains unclear whether iNKT cells are involved in DOX-induced cardiotoxicity.
Methods and results
Male C57BL/6J mice were administered DOX (20mg/kg body weight single intraperitoneal injection; n=28) or vehicle (Vehicle; n=6). DOX-administered mice were further divided into 2 groups; α-galactosylceramide (αGC, 0.1μg/g body weight twice intraperitoneal injection; DOX-αGC; n=14), which specifically activates iNKT cells, or phosphate-buffered saline alone (PBS; DOX-PBS; n=14) 4 days before and 3 days after DOX administration. Survival rate at 14 days after DOX/Vehicle administration was significantly lower in DOX-PBS than in Vehicle (71% vs. 100%, P<0.05), and this decrease was completely attenuated in DOX-αGC (100%, P<0.05 vs. DOX-PBS). Echocardiography at 14 days after DOX/Vehicle administration revealed that left ventricular (LV) fractional shortening was significantly reduced in DOX-PBS compared to Vehicle (49.3±0.8% vs. 59.2±1.7%, P<0.05), and this decrease was completely attenuated in DOX-αGC (57.7±1.3%, P<0.05 vs. DOX-PBS) without affecting LV end-diastolic diameter. Picro-sirius red staining revealed that the ratio of fibrosis area to the cardiac tissue was markedly higher in DOX-PBS than in Vehicle (4.3±0.5% vs. 2.2±0.1%, P<0.05), and this increase was completely attenuated in DOX-αGC (2.8±0.1%, P<0.05 vs. DOX-PBS). Real-time PCR analysis revealed that mRNA expression of anti-inflammatory Th2 cytokine IL-4 was enhanced by 7.9-folds in DOX-αGC compared to DOX-PBS, though the difference did not reach statistically significance (P=0.09).
Conclusions
Activation of iNKT cells by αGC ameliorates DOX-induced cardiotoxicity in mice via up-regulation of anti-inflammatory IL-4 and reducing cardiac fibrosis. iNKT cell activation may be a novel therapeutic strategy against DOX-induced cardiotoxicity.
Acknowledgement/Funding
Japan Agency for Medical Research and Development (18lm0203001j0002) and JSPS KAKENHI (18K15834)
Collapse
Affiliation(s)
- Y Obata
- Hokkaido University, Cardiovascular Medicine, Sapporo, Japan
| | - N Ishimori
- Hokkaido University, Cardiovascular Medicine, Sapporo, Japan
| | - A Saito
- Health Sciences University of Hokkaido, Cardiovascular Medicine, Sapporo, Japan
| | - S Kinugawa
- Hokkaido University, Cardiovascular Medicine, Sapporo, Japan
| | - I Nakano
- Hokkaido University, Cardiovascular Medicine, Sapporo, Japan
| | - N Kakutani
- Hokkaido University, Cardiovascular Medicine, Sapporo, Japan
| | - K Yamanashi
- Hokkaido University, Cardiovascular Medicine, Sapporo, Japan
| | - T Anzai
- Hokkaido University, Cardiovascular Medicine, Sapporo, Japan
| |
Collapse
|
16
|
Imano N, Kimura T, Kameoka T, Ochi M, Takeuchi Y, Takahashi I, Nishibuchi I, Murakami Y, Kawahara D, Miki K, Saito A, Yasushi N. P1.18-22 Impact of Using Volumetric Modulated Arc Therapy on Radiation Pneumonitis in Locally Advanced Non-Small Cell Lung Cancer. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.1338] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
17
|
Katz DL, Karlsen MC, Chung M, Shams-White MM, Green LW, Fielding J, Saito A, Willett W. Hierarchies of evidence applied to lifestyle Medicine (HEALM): introduction of a strength-of-evidence approach based on a methodological systematic review. BMC Med Res Methodol 2019; 19:178. [PMID: 31429718 PMCID: PMC6701153 DOI: 10.1186/s12874-019-0811-z] [Citation(s) in RCA: 49] [Impact Index Per Article: 9.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2019] [Accepted: 07/25/2019] [Indexed: 02/07/2023] Open
Abstract
BACKGROUND Current methods for assessing strength of evidence prioritize the contributions of randomized controlled trials (RCTs). The objective of this study was to characterize strength of evidence (SOE) tools in recent use, identify their application to lifestyle interventions for improved longevity, vitality, or successful aging, and to assess implications of the findings. METHODS The search strategy was created in PubMed and modified as needed for four additional databases: Embase, AnthropologyPlus, PsycINFO, and Ageline, supplemented by manual searching. Systematic reviews and meta-analyses of intervention trials or observational studies relevant to lifestyle intervention were included if they used a specified SOE tool. Data was collected for each SOE tool. Conditions necessary for assigning the highest SOE grading and treatment of prospective cohort studies within each SOE rating framework were summarized. The expert panel convened to discuss the implications of findings for assessing evidence in the domain of lifestyle medicine. RESULTS AND CONCLUSIONS A total of 15 unique tools were identified. Ten were tools developed and used by governmental agencies or other equivalent professional bodies and were applicable in a variety of settings. Of these 10, four require consistent results from RCTs of high quality to award the highest rating of evidence. Most SOE tools include prospective cohort studies only to note their secondary contribution to overall SOE as compared to RCTs. We developed a new construct, Hierarchies of Evidence Applied to Lifestyle Medicine (HEALM), to illustrate the feasibility of a tool based on the specific contributions of diverse research methods to understanding lifetime effects of health behaviors. Assessment of evidence relevant to lifestyle medicine requires a potential adaptation of SOE approaches when outcomes and/or exposures obviate exclusive or preferential reliance on RCTs. This systematic review was registered with the International Prospective Register of Systematic Reviews, PROSPERO [CRD42018082148].
Collapse
Affiliation(s)
- D. L. Katz
- American College of Lifestyle Medicine, PO Box 6432, Chesterfield, MO 63006 USA
- The True Health Initiative, Derby, CT USA
- Yale Griffith Prevention Research Center, 130 Division St, Derby, CT 06418 USA
| | - M. C. Karlsen
- American College of Lifestyle Medicine, PO Box 6432, Chesterfield, MO 63006 USA
- Applied Clinical Nutrition and Global Public Health Programs, University of New England, 11 Hills Beach Rd, Biddeford, ME 04005 USA
| | - M. Chung
- Department of Public Health and Community Medicine, Tufts University School of Medicine, 136 Harrison Avenue, Boston, MA 02111 USA
| | - M. M. Shams-White
- Risk Factor Assessment Branch, Division of Cancer Control and Population Sciences, National Cancer Institute, 9609 Medical Center Drive, 4E204, Bethesda, MD 20850 USA
| | - L. W. Green
- Department of Epidemiology and Biostatistics, University of California at San Francisco School of Medicine, 550 16th Street, Second Floor, San Francisco, CA 94158 USA
| | - J. Fielding
- University of California Fielding School of Public Health, 650 Charles E Young Dr S, Los Angeles, CA 90095 USA
| | - A. Saito
- Brown University School of Public Health, 121 S Main St, Providence, RI 02903 USA
| | - W. Willett
- Harvard University T.H. Chan School of Public Health, 655 Huntington Avenue, Boston, MA 02115 USA
- Harvard Medical School, 25 Shattuck St, Boston, MA 02115 USA
| |
Collapse
|
18
|
Saito A, Fujimoto M, Okiyama N. 037 Transforming growth factor-β produced by keratinocytes undergoing apoptosis promotes skin fibrosis in chronic graft-versus-host disease-like reaction. J Invest Dermatol 2019. [DOI: 10.1016/j.jid.2019.03.113] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
19
|
Kubota N, Saito A, Tanaka R, Clausen B, Fujimoto M, Okiyama N. 018 Langerhans cells suppress CD8 T cells in situ during acute graft-versus-host disease-like autoimmune mucocutaneous disease. J Invest Dermatol 2019. [DOI: 10.1016/j.jid.2019.03.094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
20
|
Hara T, Hatano M, Saito A, Minatsuki S, Maki H, Amiya E, Hosoya Y, Nagayama K, Sato M, Anraku M, Nakajima J, Komuro I. High Heart Rate and Pulmonary Vascular Resistance Predict Poor Prognosis after Referral for Lung Transplantation in Patients with Pulmonary Arterial Hypertension. J Heart Lung Transplant 2019. [DOI: 10.1016/j.healun.2019.01.1243] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
21
|
Hara T, Hatano M, Saito A, Minatsuki S, Maki H, Amiya E, Hosoya Y, Nagayama K, Sato M, Anraku M, Nakajima J, Komuro I. PROGNOSTIC FACTORS FOR PATIENTS WITH SEVERE PULMONARY ARTERIAL PULMONARY HYPERTENSION DIAGNOSED AS REQUIRING LUNG TRANSPLANTATION. Chest 2019. [DOI: 10.1016/j.chest.2019.02.313] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
22
|
Azakami D, Saito A, Ochiai K, Ishiwata T, Takahashi K, Kaji N, Kaji D, Kaji N, Michishita M. Chronic Basophilic Leukaemia in a Dog. J Comp Pathol 2018; 166:5-8. [PMID: 30691606 DOI: 10.1016/j.jcpa.2018.10.170] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2018] [Revised: 09/20/2018] [Accepted: 10/22/2018] [Indexed: 10/27/2022]
Abstract
A 13-year-old neutered female mixed-breed dog with a clinical history of emaciation, inappetence and vomiting for 2 months was presented. Blood tests showed marked leucocytosis with increased neutrophil and basophil count, mild thrombocytosis and anaemia. Seven days after the initial visit, the dog died and was submitted for necropsy examination. Grossly, the bone marrow was red in colour and hepatomegaly and splenomegaly with discolouration were observed. A bone marrow smear showed an increased proportion of basophilic lineage cells. Histologically, the bone marrow showed high cellular density and numerous basophilic lineage cells with a round or segmented nucleus. The cytoplasm contained basophilic granules exhibiting metachromasia on toluidine blue staining. Immunohistochemically, the neoplastic basophils were diffusely positive for vimentin and myeloperoxidase, but negative for CD3, BLA36, CD163, CD204 and c-kit. The immunohistochemical features of neoplastic basophils that had invaded the liver and spleen were similar to those of the basophils in the bone marrow. Based on the clinicopathological and histopathological findings, chronic basophilic leukaemia was diagnosed. The present case study provides insights into the pathological features of chronic basophilic leukaemia in dogs.
Collapse
Affiliation(s)
- D Azakami
- Department of Veterinary Nursing, School of Veterinary Nursing and Technology, Nippon Veterinary and Life Science University, Tokyo, Japan
| | - A Saito
- Department of Veterinary Pathology, School of Veterinary Medicine, Nippon Veterinary and Life Science University, Tokyo, Japan
| | - K Ochiai
- Department of Basic Science, School of Veterinary Nursing and Technology, Nippon Veterinary and Life Science University, Tokyo, Japan
| | - T Ishiwata
- Division of Aging and Carcinogenesis, Research Team for Geriatric Pathology, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan
| | - K Takahashi
- Department of Veterinary Pathology, School of Veterinary Medicine, Nippon Veterinary and Life Science University, Tokyo, Japan
| | - N Kaji
- Kaji Animal Clinic, Fukuoka, Japan
| | - D Kaji
- Kaji Animal Clinic, Fukuoka, Japan
| | - N Kaji
- Kaji Animal Clinic, Fukuoka, Japan
| | - M Michishita
- Department of Veterinary Pathology, School of Veterinary Medicine, Nippon Veterinary and Life Science University, Tokyo, Japan.
| |
Collapse
|
23
|
Okiyama N, Inoue S, Saito A, Nakamura Y, Ishitsuka Y, Fujisawa Y, Watanabe R, Fujimoto M. Antihelix/helix violaceous macules in Japanese patients with anti-melanoma differentiation-associated protein 5 (MDA5) antibody-associated dermatomyositis. Br J Dermatol 2018; 180:1226-1227. [PMID: 30431155 DOI: 10.1111/bjd.17431] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Affiliation(s)
- N Okiyama
- University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575,, Japan
| | - S Inoue
- University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575,, Japan
| | - A Saito
- University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575,, Japan
| | - Y Nakamura
- University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575,, Japan
| | - Y Ishitsuka
- University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575,, Japan
| | - Y Fujisawa
- University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575,, Japan
| | - R Watanabe
- University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575,, Japan
| | - M Fujimoto
- University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575,, Japan
| |
Collapse
|
24
|
Inoue S, Okiyama N, Shobo M, Motegi S, Hirano H, Nakagawa Y, Saito A, Nakamura Y, Ishitsuka Y, Fujisawa Y, Watanabe R, Fujimoto M. Diffuse erythema with ‘angel wings’ sign in Japanese patients with anti-small ubiquitin-like modifier activating enzyme antibody-associated dermatomyositis. Br J Dermatol 2018; 179:1414-1415. [DOI: 10.1111/bjd.17026] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
Affiliation(s)
- S. Inoue
- Department of Dermatology, Faculty of Medicine; University of Tsukuba; Ibaraki Japan
| | - N. Okiyama
- Department of Dermatology, Faculty of Medicine; University of Tsukuba; Ibaraki Japan
| | - M. Shobo
- Department of Dermatology, Faculty of Medicine; University of Tsukuba; Ibaraki Japan
| | - S. Motegi
- Department of Dermatology, Graduate School of Medicine; Gunma University; Gunma Japan
| | - H. Hirano
- Department of Neurology; Kansai Electric Power Hospital; Osaka Japan
| | - Y. Nakagawa
- Department of Neurology; Shizuoka General Hospital; Shizuoka Japan
| | - A. Saito
- Department of Dermatology, Faculty of Medicine; University of Tsukuba; Ibaraki Japan
| | - Y. Nakamura
- Department of Dermatology, Faculty of Medicine; University of Tsukuba; Ibaraki Japan
| | - Y. Ishitsuka
- Department of Dermatology, Faculty of Medicine; University of Tsukuba; Ibaraki Japan
| | - Y. Fujisawa
- Department of Dermatology, Faculty of Medicine; University of Tsukuba; Ibaraki Japan
| | - R. Watanabe
- Department of Dermatology, Faculty of Medicine; University of Tsukuba; Ibaraki Japan
| | - M. Fujimoto
- Department of Dermatology, Faculty of Medicine; University of Tsukuba; Ibaraki Japan
| |
Collapse
|
25
|
Nambu H, Takada S, Fukushima A, Matsumoto J, Kakutani N, Maekawa S, Shirakawa R, Furihata T, Nakajima T, Katayama T, Tsuda M, Saito A, Yokota T, Kinugawa S, Anzai T. P4774Empagliflozin improves exercise endurance via the activation of fatty acid oxidation in the skeletal muscle in murine model of post-infarct heart failure. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy563.p4774] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- H Nambu
- Hokkaido University, Cardiovascular medicine, Sapporo, Japan
| | - S Takada
- Hokkaido University, Cardiovascular medicine, Sapporo, Japan
| | - A Fukushima
- Hokkaido University, Cardiovascular medicine, Sapporo, Japan
| | - J Matsumoto
- Hokkaido University, Cardiovascular medicine, Sapporo, Japan
| | - N Kakutani
- Hokkaido University, Cardiovascular medicine, Sapporo, Japan
| | - S Maekawa
- Hokkaido University, Cardiovascular medicine, Sapporo, Japan
| | - R Shirakawa
- Hokkaido University, Cardiovascular medicine, Sapporo, Japan
| | - T Furihata
- Hokkaido University, Cardiovascular medicine, Sapporo, Japan
| | - T Nakajima
- Hokkaido University, Cardiovascular medicine, Sapporo, Japan
| | - T Katayama
- Hokkaido University, Cardiovascular medicine, Sapporo, Japan
| | - M Tsuda
- Hokkaido University, Cardiovascular medicine, Sapporo, Japan
| | - A Saito
- Hokkaido University, Cardiovascular medicine, Sapporo, Japan
| | - T Yokota
- Hokkaido University, Cardiovascular medicine, Sapporo, Japan
| | - S Kinugawa
- Hokkaido University, Cardiovascular medicine, Sapporo, Japan
| | - T Anzai
- Hokkaido University, Cardiovascular medicine, Sapporo, Japan
| |
Collapse
|
26
|
Shirakawa R, Yokota T, Nakajima T, Takada S, Yamane M, Furihata T, Matsumoto J, Tsuda M, Katayama T, Maekawa S, Nambu H, Fukushima A, Saito A, Kinugawa S, Anzai T. 3143Excessive mitochondrial reactive oxygen species emission from circulating blood cells is associated with severity of heart failure and exercise intolerance. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy563.3143] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- R Shirakawa
- Hokkaido University, Cardiovascular Medicine, Sapporo, Japan
| | - T Yokota
- Hokkaido University, Cardiovascular Medicine, Sapporo, Japan
| | - T Nakajima
- Hokkaido University, Cardiovascular Medicine, Sapporo, Japan
| | - S Takada
- Hokkaido University, Cardiovascular Medicine, Sapporo, Japan
| | - M Yamane
- Hokkaido University, Cardiovascular Medicine, Sapporo, Japan
| | - T Furihata
- Hokkaido University, Cardiovascular Medicine, Sapporo, Japan
| | - J Matsumoto
- Hokkaido University, Cardiovascular Medicine, Sapporo, Japan
| | - M Tsuda
- Hokkaido University, Cardiovascular Medicine, Sapporo, Japan
| | - T Katayama
- Hokkaido University, Cardiovascular Medicine, Sapporo, Japan
| | - S Maekawa
- Hokkaido University, Cardiovascular Medicine, Sapporo, Japan
| | - H Nambu
- Hokkaido University, Cardiovascular Medicine, Sapporo, Japan
| | - A Fukushima
- Hokkaido University, Cardiovascular Medicine, Sapporo, Japan
| | - A Saito
- Hokkaido University, Cardiovascular Medicine, Sapporo, Japan
| | - S Kinugawa
- Hokkaido University, Cardiovascular Medicine, Sapporo, Japan
| | - T Anzai
- Hokkaido University, Cardiovascular Medicine, Sapporo, Japan
| |
Collapse
|
27
|
Nitta D, Kinugawa K, Yokota J, Endo M, Tsuji M, Saito A, Minatsuki S, Amiya E, Hatano M, Ono M, Komuro I. The Presence of Microchannel in Optical Coherence Tomography is Associated With the Plaque Volume of Cardiac Allograft Vasculopathy After Heart Transplantation. J Heart Lung Transplant 2018. [DOI: 10.1016/j.healun.2018.01.1071] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
28
|
Tabeta K, Hosojima M, Nakajima M, Miyauchi S, Miyazawa H, Takahashi N, Matsuda Y, Sugita N, Komatsu Y, Sato K, Ishikawa T, Akiishi K, Yamazaki K, Kato K, Saito A, Yoshie H. Increased serum PCSK9, a potential biomarker to screen for periodontitis, and decreased total bilirubin associated with probing depth in a Japanese community survey. J Periodontal Res 2018. [DOI: 10.1111/jre.12533] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Affiliation(s)
- K. Tabeta
- Division of Periodontology; Department of Oral Biological Science; Niigata University Graduate School of Medical and Dental Science; Niigata Japan
| | - M. Hosojima
- Department of Clinical Nutrition Science; Niigata University Graduate School of Medical and Dental Sciences; Niigata Japan
| | - M. Nakajima
- Division of Periodontology; Department of Oral Biological Science; Niigata University Graduate School of Medical and Dental Science; Niigata Japan
| | - S. Miyauchi
- Division of Periodontology; Department of Oral Biological Science; Niigata University Graduate School of Medical and Dental Science; Niigata Japan
| | - H. Miyazawa
- Division of Periodontology; Department of Oral Biological Science; Niigata University Graduate School of Medical and Dental Science; Niigata Japan
| | - N. Takahashi
- Division of Periodontology; Department of Oral Biological Science; Niigata University Graduate School of Medical and Dental Science; Niigata Japan
| | - Y. Matsuda
- Division of Periodontology; Department of Oral Biological Science; Niigata University Graduate School of Medical and Dental Science; Niigata Japan
| | - N. Sugita
- Division of Periodontology; Department of Oral Biological Science; Niigata University Graduate School of Medical and Dental Science; Niigata Japan
| | - Y. Komatsu
- Division of Periodontology; Department of Oral Biological Science; Niigata University Graduate School of Medical and Dental Science; Niigata Japan
| | - K. Sato
- Division of Periodontology; Department of Oral Biological Science; Niigata University Graduate School of Medical and Dental Science; Niigata Japan
| | - T. Ishikawa
- Division of Clinical Nephrology and Rheumatology; Niigata University Graduate School of Medical and Dental Sciences; Niigata Japan
| | - K. Akiishi
- Reagent R&D Department; Denka Seiken Co., Ltd.; Niigata Japan
| | - K. Yamazaki
- Laboratory of Periodontology and Immunology; Department of Oral Health and Welfare; Faculty of Dentistry; Niigata University; Niigata Japan
| | - K. Kato
- Department of Laboratory Medicine and Clinical Epidemiology for Prevention of Noncommunicable Diseases; Niigata University Graduate School of Medical and Dental Sciences; Niigata Japan
| | - A. Saito
- Department of Applied Molecular Medicine; Niigata University Graduate School of Medical and Dental Sciences; Niigata Japan
| | - H. Yoshie
- Division of Periodontology; Department of Oral Biological Science; Niigata University Graduate School of Medical and Dental Science; Niigata Japan
| |
Collapse
|
29
|
Immel TJ, England SL, Mende SB, Heelis RA, Englert CR, Edelstein J, Frey HU, Korpela EJ, Taylor ER, Craig WW, Harris SE, Bester M, Bust GS, Crowley G, Forbes JM, Gérard JC, Harlander JM, Huba JD, Hubert B, Kamalabadi F, Makela JJ, Maute AI, Meier RR, Raftery C, Rochus P, Siegmund OHW, Stephan AW, Swenson GR, Frey S, Hysell DL, Saito A, Rider KA, Sirk MM. The Ionospheric Connection Explorer Mission: Mission Goals and Design. Space Sci Rev 2017; 214:13. [PMID: 33758433 PMCID: PMC7983873 DOI: 10.1007/s11214-017-0449-2] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/30/2016] [Accepted: 11/17/2017] [Indexed: 06/01/2023]
Abstract
The Ionospheric Connection Explorer, or ICON, is a new NASA Explorer mission that will explore the boundary between Earth and space to understand the physical connection between our world and our space environment. This connection is made in the ionosphere, which has long been known to exhibit variability associated with the sun and solar wind. However, it has been recognized in the 21st century that equally significant changes in ionospheric conditions are apparently associated with energy and momentum propagating upward from our own atmosphere. ICON's goal is to weigh the competing impacts of these two drivers as they influence our space environment. Here we describe the specific science objectives that address this goal, as well as the means by which they will be achieved. The instruments selected, the overall performance requirements of the science payload and the operational requirements are also described. ICON's development began in 2013 and the mission is on track for launch in 2017. ICON is developed and managed by the Space Sciences Laboratory at the University of California, Berkeley, with key contributions from several partner institutions.
Collapse
Affiliation(s)
- T J Immel
- University of California, Berkeley, USA
| | - S L England
- Virginia Polytechnic Institute and State University, Blacksburg, VA, USA
| | - S B Mende
- University of California, Berkeley, USA
| | - R A Heelis
- University of Texas at Dallas, Dallas, USA
| | - C R Englert
- Naval Research Laboratory, Washington, DC, USA
| | | | - H U Frey
- University of California, Berkeley, USA
| | | | | | - W W Craig
- University of California, Berkeley, USA
| | | | - M Bester
- University of California, Berkeley, USA
| | - G S Bust
- Applied Physics Laboratory, Laurel, MD, USA
| | | | - J M Forbes
- University of Colorado, Boulder, CO, USA
| | | | | | - J D Huba
- Naval Research Laboratory, Washington, DC, USA
| | - B Hubert
- University of Liège, Liège, Belgium
| | | | - J J Makela
- University of Illinois, Champaign-Urbana, USA
| | - A I Maute
- National Center for Atmospheric Research, Boulder, CO, USA
| | - R R Meier
- George Mason University, Fairfax, VA, USA
| | - C Raftery
- University of California, Berkeley, USA
- National Solar Observatory, Boulder, CO, USA
| | - P Rochus
- University of Liège, Liège, Belgium
| | | | - A W Stephan
- Naval Research Laboratory, Washington, DC, USA
| | - G R Swenson
- University of Illinois, Champaign-Urbana, USA
| | - S Frey
- University of California, Berkeley, USA
| | | | - A Saito
- Kyoto University, Kyoto, Japan
| | - K A Rider
- University of California, Berkeley, USA
| | - M M Sirk
- University of California, Berkeley, USA
| |
Collapse
|
30
|
Corassa M, De Sa V, Werneck I, Lima V, Saito A, Molin GD, De Macedo M, Ferreira E, Carraro D, Freitas H. P3.02-060 EGFR Mutation Status by Three Sequencing Platforms in 704 Non-Small Cell Lung Cancer (NSCLC) Brazilian Patients. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.1589] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
31
|
Hisanaga Y, Suzuki E, Aoki H, Sato M, Saito A, Saito A, Azuma T. Effect of the combined use of enamel matrix derivative and atelocollagen sponge scaffold on osteoblastic differentiation of mouse induced pluripotent stem cells in vitro. J Periodontal Res 2017; 53:240-249. [PMID: 29044527 DOI: 10.1111/jre.12511] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/07/2017] [Indexed: 12/16/2022]
Abstract
BACKGROUND AND OBJECTIVE Induced pluripotent stem cells (iPSCs) are a candidate cell source in periodontal regenerative therapy. Enamel matrix derivative (EMD) has been shown to regenerate periodontal tissues, and atelocollagen sponge (ACS) is considered a suitable scaffold or carrier for growth factors. This study aimed to investigate the effect of combined use of EMD and an ACS scaffold on cell behaviors and differentiation of mouse iPSCs (miPSCs) in vitro. MATERIAL AND METHODS Following embryonic body formation from miPSCs, dissociated cells (miPS-EB-derived cells) were seeded onto ACS with or without EMD, and cultured in osteoblast differentiation medium. Scanning electron microscopy and histological analyses were used to assess cell morphology and infiltration within the ACS. Cell viability (metabolism) was determined using an MTS assay, and expression of mRNA of osteoblastic differentiation markers was assessed by quantitative RT -PCR. Alkaline phosphatase (ALP) staining intensity and activity were evaluated. Mineralization was assessed by von Kossa staining, and calcium content was quantitated using the methylxylenol blue method. RESULTS By 24 hours after seeding, miPS-EB-derived cells in both the EMD and control groups had attached to and infiltrated the ACS scaffold. Scanning electron microscopy images revealed that by day 14, many cytoplasmic protrusions and extracellular deposits, suggestive of calcified matrix, were present in the EMD group. There was a time-dependent increase in cell viability up to day 3, but no difference between groups was observed at any time point. The levels expressed of ALP and osterix genes were significantly higher in the EMD group than in the control group. Expression of runt-related transcription factor 2 was increased in the EMD group compared with the control group on day 7. EMD upregulated the expression of bone sialoprotein and osteopontin on day 14, whereas expression of osteocalcin was lower at all time points. The staining intensity and activity of ALP were higher in the EMD group than in the control group. Mineralization levels and calcium contents were significantly higher in the EMD group throughout the observation period. CONCLUSION These data suggest that combining ACS with EMD increases levels of osteoblastic differentiation and mineralization in miPS-EB-derived cells, compared with ACS used alone.
Collapse
Affiliation(s)
- Y Hisanaga
- Department of Periodontology, Tokyo Dental College, Tokyo, Japan
| | - E Suzuki
- Department of Periodontology, Tokyo Dental College, Tokyo, Japan
| | - H Aoki
- Department of Periodontology, Tokyo Dental College, Tokyo, Japan
| | - M Sato
- Department of Periodontology, Tokyo Dental College, Tokyo, Japan
| | - A Saito
- Department of Biochemistry, Tokyo Dental College, Tokyo, Japan.,Oral Health Science Center, Tokyo Dental College, Tokyo, Japan
| | - A Saito
- Department of Periodontology, Tokyo Dental College, Tokyo, Japan.,Oral Health Science Center, Tokyo Dental College, Tokyo, Japan
| | - T Azuma
- Department of Biochemistry, Tokyo Dental College, Tokyo, Japan.,Oral Health Science Center, Tokyo Dental College, Tokyo, Japan
| |
Collapse
|
32
|
Saito A, Okiyama N, Kubota N, Fujimoto M. 666 Interferon-γ deficiency attenuates skin fibrosis in a murine model of chronic graft-versus-host disease-like scleroderma. J Invest Dermatol 2017. [DOI: 10.1016/j.jid.2017.07.343] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
33
|
Izaki S, Hashimoto B, Yamaga T, Furuya M, Miyauchi A, Tanaka S, Ishizuka K, Suzuki M, Saito A, Kubota A, Tajima T, Narukawa S, Hara W, Yoshida N, Oji S, Dembo T, Fukaura H, Nomura K. Current status of MG-QOL 15-J score in Saitama prefecture 2017. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.3528] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
34
|
Miki K, Saito A, Nakashima T, Nagata Y. The Planning Configurations Optimization for Treatment Planning of VMAT With Design of Experiments. Int J Radiat Oncol Biol Phys 2017. [DOI: 10.1016/j.ijrobp.2017.06.2283] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
35
|
Oji S, Narukawa S, Ishizuka K, Hashimoto B, Yamaga T, Furuya M, Miyauchi A, Tanaka S, Suzuki M, Saito A, Tajima T, Hara W, Kubota A, Izaki S, Yoshida N, Dembo T, Fukaura H, Kaida K, Nomura K. Serum potassium level and short-term prognosis in patients with anti-GM1 antibody positive Guillan-Barre syndrome - preliminary study -. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.1854] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
36
|
Higashiyama Y, Saito A, Kimura K, Joki H, Kishida H, Doi H, Ueda N, Takeuchi H, Tanaka F. Callosal disconnection syndromes in idiopathic normal pressure hydrocephalus: structural and functional neuroimaging study. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.320] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
37
|
Kubota A, Fukaura H, Tanaka S, Miyauchi A, Furuya M, Ishizuka K, Suzuki M, Saito A, Narukawa S, Hara W, Tajima T, Izaki S, Yoshida N, Ohji S, Dembo T, Nomura K. Influence of fingolimod on CD4 T cell subsets in the peripheral blood of patients with multiple sclerosis. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.1827] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
38
|
Nishibuchi I, Murakami Y, Imano N, Takeuchi Y, Takahashi I, Miki K, Saito A, Kimura T, Wadasaki K, Nagata Y. Long-Term Results of Definitive Chemoradiation Therapy for Elderly Patients With Esophageal Cancer. Int J Radiat Oncol Biol Phys 2017. [DOI: 10.1016/j.ijrobp.2017.06.1026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
39
|
Nakajima T, Ono Y, Kaneko Y, Saito A, Imai M, Iizuka T, Irie T, Funada R, Takama N, Kasama S, Nakamura K, Niwamae N, Tange S, Kurabayashi M. P799The clinical and genetic predispositions to ventricular tachyarrhythmias associated with vasospastic angina. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx501.p799] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
40
|
Umeda Y, Hasegawa Y, Otsuka M, Ariki S, Takamiya R, Saito A, Uehara Y, Saijo H, Kuronuma K, Chiba H, Ohnishi H, Sakuma Y, Takahashi H, Kuroki Y, Takahashi M. Surfactant protein D inhibits activation of non-small cell lung cancer-associated mutant EGFR and affects clinical outcomes of patients. Oncogene 2017; 36:6432-6445. [PMID: 28745320 DOI: 10.1038/onc.2017.253] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2016] [Revised: 03/21/2017] [Accepted: 06/19/2017] [Indexed: 12/17/2022]
Abstract
Tyrosine kinase inhibitor (TKI)-sensitive and TKI-resistant mutations of epidermal growth factor receptor (EGFR) are associated with lung adenocarcinoma. EGFR mutants were previously shown to exhibit ligand-independent activation. We have previously demonstrated that pulmonary surfactant protein D (SP-D, SFTPD) suppressed wild-type EGFR signaling by blocking ligand binding to EGFR. We herein demonstrate that SFTPD downregulates ligand-independent signaling in cells harboring EGFR mutations such as TKI-sensitive exon 19 deletion (Ex19del) and L858R mutation as well as TKI-resistant T790M mutation, subsequently suppressing cellular growth and motility. Lectin blotting and ligand blotting in lung cancer cell lines suggested that EGFR mutants express oligomannose-type N-glycans and interact with SFTPD directly. Cross-linking assay indicated that SFTPD inhibits ligand-independent dimerization of EGFR mutants. We also demonstrated that SFTPD reduced dimerization-independent phosphorylation of Ex19del and T790M EGFR mutants using point mutations that disrupted the asymmetric dimer interface. It was confirmed that SFTPD augmented the viability-suppressing effects of EGFR-TKIs. Furthermore, retrospective analysis of 121 patients with lung adenocarcinoma to examine associations between serum SFTPD levels and clinical outcome indicated that in TKI-treated patients with lung cancer harboring EGFR mutations, including Ex19del or L858R, high serum SFTPD levels correlated with a lower number of distant metastases and prolonged overall survival and progression-free survival. These findings suggest that SFTPD downregulates both TKI-sensitive and -resistant EGFR mutant signaling, and SFTPD level is correlated with clinical outcome. These findings illustrate the use of serum SFTPD level as a potential marker to estimate the efficacy of EGFR-TKIs.
Collapse
Affiliation(s)
- Y Umeda
- Departments of Respiratory Medicine and Allergology, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan
| | - Y Hasegawa
- Departments of Respiratory Medicine and Allergology, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.,Departments of Biochemistry, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan
| | - M Otsuka
- Departments of Respiratory Medicine and Allergology, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan
| | - S Ariki
- Departments of Biochemistry, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan
| | - R Takamiya
- Departments of Biochemistry, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan
| | - A Saito
- Departments of Respiratory Medicine and Allergology, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.,Departments of Biochemistry, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan
| | - Y Uehara
- Departments of Respiratory Medicine and Allergology, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.,Departments of Biochemistry, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan
| | - H Saijo
- Departments of Respiratory Medicine and Allergology, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan
| | - K Kuronuma
- Departments of Respiratory Medicine and Allergology, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan
| | - H Chiba
- Departments of Respiratory Medicine and Allergology, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan
| | - H Ohnishi
- Departments of Public Health, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan
| | - Y Sakuma
- Departments of Molecular Medicine, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan
| | - H Takahashi
- Departments of Respiratory Medicine and Allergology, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan
| | - Y Kuroki
- Departments of Biochemistry, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan
| | - M Takahashi
- Departments of Biochemistry, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan
| |
Collapse
|
41
|
Maeo S, Saito A, Otsuka S, Shan X, Kanehisa H, Kawakami Y. Localization of muscle damage within the quadriceps femoris induced by different types of eccentric exercises. Scand J Med Sci Sports 2017; 28:95-106. [DOI: 10.1111/sms.12880] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/13/2017] [Indexed: 01/22/2023]
Affiliation(s)
- S. Maeo
- Faculty of Sport Sciences; Waseda University; Tokorozawa Saitama Japan
- Research Fellow of Japan Society for the Promotion of Science; Chiyoda Tokyo Japan
| | - A. Saito
- Faculty of Sport Sciences; Waseda University; Tokorozawa Saitama Japan
| | - S. Otsuka
- Faculty of Sport Sciences; Waseda University; Tokorozawa Saitama Japan
| | - X. Shan
- Faculty of Sport Sciences; Waseda University; Tokorozawa Saitama Japan
| | - H. Kanehisa
- Department of Sports and Life Science; National Institute of Fitness and Sports in Kanoya; Kanoya Kagoshima Japan
| | - Y. Kawakami
- Faculty of Sport Sciences; Waseda University; Tokorozawa Saitama Japan
| |
Collapse
|
42
|
Kakuta E, Nomura Y, Morozumi T, Nakagawa T, Nakamura T, Noguchi K, Yoshimura A, Hara Y, Fujise O, Nishimura F, Kono T, Umeda M, Fukuda M, Noguchi T, Yoshinari N, Fukaya C, Sekino S, Numabe Y, Sugano N, Ito K, Kobayashi H, Izumi Y, Takai H, Ogata Y, Takano S, Minabe M, Makino-Oi A, Saito A, Abe Y, Sato S, Suzuki F, Takahashi K, Sugaya T, Kawanami M, Hanada N, Takashiba S, Yoshie H. Assessing the progression of chronic periodontitis using subgingival pathogen levels: a 24-month prospective multicenter cohort study. BMC Oral Health 2017; 17:46. [PMID: 28093069 PMCID: PMC5240246 DOI: 10.1186/s12903-017-0337-x] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2016] [Accepted: 01/06/2017] [Indexed: 01/08/2023] Open
Abstract
BACKGROUND The diagnosis of the progression of periodontitis presently depends on the use of clinical symptoms (such as attachment loss) and radiographic imaging. The aim of the multicenter study described here was to evaluate the diagnostic use of the bacterial content of subgingival plaque recovered from the deepest pockets in assessing disease progression in chronic periodontitis patients. METHODS This study consisted of a 24-month investigation of a total of 163 patients with chronic periodontitis who received trimonthly follow-up care. Subgingival plaque from the deepest pockets was recovered and assessed for bacterial content of Porphyromonas gingivalis, Prevotella intermedia, and Aggregatibacter actinomycetemcomitans using the modified Invader PLUS assay. The corresponding serum IgG titers were measured using ELISA. Changes in clinical parameters were evaluated over the course of 24 months. The sensitivity, specificity, and prediction values were calculated and used to determine cutoff points for prediction of the progression of chronic periodontitis. RESULTS Of the 124 individuals who completed the 24-month monitoring phase, 62 exhibited progression of periodontitis, whereas 62 demonstrated stable disease. The P. gingivalis counts of subgingival plaque from the deepest pockets was significantly associated with the progression of periodontitis (p < 0.001, positive predictive value = 0.708). CONCLUSIONS The P. gingivalis counts of subgingival plaque from the deepest pockets may be associated with the progression of periodontitis.
Collapse
Affiliation(s)
- E Kakuta
- Department of Oral Microbiology, Tsurumi University School of Dental Medicine, 2-1-3 Tsurumi, Tsurumi-ku, Yokohama, Japan
| | - Y Nomura
- Department of Translational Research, Tsurumi University School of Dental Medicine, 2-1-3 Tsurumi, Tsurumi-ku, Yokohama, 230-8501, Japan.
| | - T Morozumi
- Division of Periodontology, Department of Oral Biological Science, Niigata University Graduate School of Medical and Dental Sciences, 2-5274 Gakkocho-dori, Chuo-ku, Niigata, Japan
| | - T Nakagawa
- Department of Dentistry and Oral Surgery, School of Medicine, Keio University, 35 Shinano-machi, Shinjuku-ku, Tokyo, Japan
| | - T Nakamura
- Department of Periodontology, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima, Japan
| | - K Noguchi
- Department of Periodontology, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima, Japan
| | - A Yoshimura
- Department of Periodontology, Unit of Translational Medicine, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki, Japan
| | - Y Hara
- Department of Periodontology, Unit of Translational Medicine, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki, Japan
| | - O Fujise
- Section of Periodontology, Division of Oral Rehabilitation, Faculty of Dental Science, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, Japan
| | - F Nishimura
- Section of Periodontology, Division of Oral Rehabilitation, Faculty of Dental Science, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, Japan
| | - T Kono
- Department of Periodontology, Osaka Dental University, 8-1 Kuzuhahanazonocho, Hirakata, Japan
| | - M Umeda
- Department of Periodontology, Osaka Dental University, 8-1 Kuzuhahanazonocho, Hirakata, Japan
| | - M Fukuda
- Department of Periodontology, School of Dentistry, Aichi Gakuin University, 2-11 Suemori-doori,Chikusa-ku, Nagoya, Japan
| | - T Noguchi
- Department of Periodontology, School of Dentistry, Aichi Gakuin University, 2-11 Suemori-doori,Chikusa-ku, Nagoya, Japan
| | - N Yoshinari
- Department of Periodontology, School of Dentistry, Matsumoto Dental University, 1780 Hirokagobara, Shiojiri, Nagano, Japan
| | - C Fukaya
- Department of Dentistry and Oral Surgery, School of Medicine, Keio University, 35 Shinano-machi, Shinjuku-ku, Tokyo, Japan
| | - S Sekino
- Department of Periodontology, School of Life Dentistry at Tokyo, The Nippon Dental University, 1-9-20 Fujimi, Chiyoda-ku, Tokyo, Japan
| | - Y Numabe
- Department of Periodontology, School of Life Dentistry at Tokyo, The Nippon Dental University, 1-9-20 Fujimi, Chiyoda-ku, Tokyo, Japan
| | - N Sugano
- Department of Periodontology, Nihon University School of Dentistry, 1-8-13 Kanda-Surugadai, Chiyoda-ku, Tokyo, Japan
| | - K Ito
- Department of Periodontology, Nihon University School of Dentistry, 1-8-13 Kanda-Surugadai, Chiyoda-ku, Tokyo, Japan
| | - H Kobayashi
- Department of Periodontology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, Japan
| | - Y Izumi
- Department of Periodontology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, Japan
| | - H Takai
- Department of Periodontology, Nihon University School of Dentistry at Matsudo, 2-870-1 Sakae-cho-nishi, Matsudo-shi, Chiba, Japan
| | - Y Ogata
- Department of Periodontology, Nihon University School of Dentistry at Matsudo, 2-870-1 Sakae-cho-nishi, Matsudo-shi, Chiba, Japan
| | - S Takano
- Bunkyo-Dori Dental Clinic, 2-4-1 Anagawa, Inage-ku, Chiba, Japan
| | - M Minabe
- Bunkyo-Dori Dental Clinic, 2-4-1 Anagawa, Inage-ku, Chiba, Japan.,Division of Periodontology, Department of Oral function and Restoration, School of Dentistry, Kanagawa Dental University, 82 Inaokacho, Yokosuka, Kanagawa, Japan
| | - A Makino-Oi
- Department of Periodontology, Tokyo Dental College, 2-9-18 Misakicho, Chiyoda-ku, Tokyo, Japan
| | - A Saito
- Department of Periodontology, Tokyo Dental College, 2-9-18 Misakicho, Chiyoda-ku, Tokyo, Japan
| | - Y Abe
- Comprehensive Dental Care, The Nippon Dental University Niigata Hospital, 1-8 Hamaura-cho, Chuo-ku, Niigata, Japan
| | - S Sato
- Department of Periodontology, School of life Dentistry at Niigata, The Nippon Dental University, 1-8 Hamaura-cho, Chuo-ku, Niigata, Japan
| | - F Suzuki
- Division of Dental Anesthesiology, Department of Oral Surgery, School of Dentistry, Ohu University, 31-1 Misumido, Tomita, Koriyama, Fukushima, Japan
| | - K Takahashi
- Division of Periodontics, Department of Conservative Dentistry, School of Dentistry, Ohu University, 31-1 Misumido, Tomita, Koriyama, Fukushima, Japan
| | - T Sugaya
- Division of Periodontology and Endodontology, Department of Oral Health Science, Hokkaido University Graduate School of Dental Medicine, Kita 13, Nishi 7, Kita-ku, Sapporo, Japan
| | - M Kawanami
- Division of Periodontology and Endodontology, Department of Oral Health Science, Hokkaido University Graduate School of Dental Medicine, Kita 13, Nishi 7, Kita-ku, Sapporo, Japan
| | - N Hanada
- Department of Translational Research, Tsurumi University School of Dental Medicine, 2-1-3 Tsurumi, Tsurumi-ku, Yokohama, 230-8501, Japan
| | - S Takashiba
- Department of Pathophysiology-Periodontal Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Okayama, Japan
| | - H Yoshie
- Division of Periodontology, Department of Oral Biological Science, Niigata University Graduate School of Medical and Dental Sciences, 2-5274 Gakkocho-dori, Chuo-ku, Niigata, Japan
| |
Collapse
|
43
|
Saito A, Okada K, Saito I, Kinoshita K, Seto A, Takahashi Y, Shibata K, Sato H, Wakasa M. Functional status of the articularis genus muscle in individuals with knee osteoarthritis. J Musculoskelet Neuronal Interact 2016; 16:348-354. [PMID: 27973387 PMCID: PMC5259576] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
OBJECTIVES To clarify the functional status of the articularis genus muscle (AGM) in individuals with knee osteoarthritis (OA) and to analyze the muscle's relationship with knee OA. METHODS Fifty-two individuals with knee OA (mean age, 73.4 years), 50 elderly individuals without knee OA changes (mean age, 71.2 years) and 75 young individuals (mean age, 20.2 years) were observed the AGM using ultrasonography. The thickness of the AGM, the anteroposterior distance of the suprapatellar bursa, and moving distance of the muscle insertion were measured both at rest and during isometric contraction, and values during contraction were expressed as percentages of the values at rest (%Muscle-Increase, %Bursa-Increase). RESULTS Muscle thickness at rest, %Muscle-Increase, %Bursa-Increase, and moving distance of the muscle insertion were significantly lower and anteroposterior distance of the suprapatellar bursa was significantly higher in the OA group than in the controls (p<0.001, all). In the OA group, these values for the AGM were significantly correlated with knee range of motion, knee pain, and Kellgren and Lawrence grade. CONCLUSIONS Individuals with knee OA exhibited atrophic changes and dysfunctions of the AGM, and these were associated with symptoms. Atrophic changes and dysfunctions of the AGM may be specific changes associated with knee OA.
Collapse
Affiliation(s)
- A. Saito
- Department of Physical Therapy, Akita University Graduate School of Health Sciences, Akita, Japan
| | - K. Okada
- Department of Physical Therapy, Akita University Graduate School of Health Sciences, Akita, Japan
| | - I. Saito
- Department of Rehabilitation, Ugo Municipal Hospital, Ugo, Japan,Corresponding author: Akira Saito, Department of Physical Therapy, Akita University Graduate School of Health Sciences, 1-1-1 Hondo, Akita, 010-8543, Japan E-mail:
| | - K. Kinoshita
- Department of Rehabilitation, Sannoh Orthopedic Clinic, Akita, Japan
| | - A. Seto
- Department of Rehabilitation, Sannoh Orthopedic Clinic, Akita, Japan
| | - Y. Takahashi
- Department of Rehabilitation, Akita University Hospital, Akita, Japan
| | - K. Shibata
- Department of Rehabilitation, Akita City Hospital, Akita, Japan
| | - H. Sato
- Department of Rehabilitation, Akita Kousei Medical Center, Akita, Japan
| | - M. Wakasa
- Department of Physical Therapy, Akita University Graduate School of Health Sciences, Akita, Japan
| |
Collapse
|
44
|
Imamura K, Kokubu E, Kita D, Ota K, Yoshikawa K, Ishihara K, Saito A. Role of mitogen-activated protein kinase pathways in migration of gingival epithelial cells in response to stimulation by cigarette smoke condensate and infection by Porphyromonas gingivalis. J Periodontal Res 2016; 51:613-21. [PMID: 26667496 DOI: 10.1111/jre.12341] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/11/2015] [Indexed: 01/14/2023]
Abstract
BACKGROUND AND OBJECTIVE Previous studies have shown that cigarette smoke (CS) and periodontal pathogens could alter wound healing responses of gingival epithelial cells. To elucidate molecular mechanisms leading to these epithelial changes, we studied the signaling pathway involved in the modulation of cell migration by CS condensate (CSC) and the infection by a prominent periodontal pathogen, Porphyromonas gingivalis. MATERIAL AND METHODS Human gingival epithelial cells (Ca9-22) were treated with CSC or vehicle control for 24 h. Activation of mitogen-activated protein kinases (MAPK) in cells with or without infection by P. gingivalis was assessed by polymerase chain reaction array and immunoblotting using phospho-specific antibodies. Cell migration was assessed using in vitro wound closure model, and specific pharmacologic inhibitors of MAPK pathways were used to characterize further the extent of involvement of the MAPK pathways. RESULTS Polymerase chain reaction array showed that gene expression of several members of the MAPK, particularly p38 and JNK, was upregulated more than twofold in Ca9-22 cells stimulated with 10 μg/mL CSC. Coincubation with P. gingivalis induced a different pattern of gene expression for MAPK pathways, but it did not suppress the MAPK-related genes upregulated by CSC. A significant phosphorylation of ERK1/2 and p38 was observed in cells stimulated with 10 μg/mL CSC (p < 0.05), whereas coincubation with a higher concentration of CSC (250 μg/mL) evoked no such activation. P. gingivalis infection resulted in a tendency to reduce the phosphorylation of ERK1/2 and p38, which had been enhanced by stimulation with 10 μg/mL CSC. Incubation with ERK1/2 and p38 inhibitors significantly reduced the wound closure of CSC-stimulated cells, by approximately 43% and 46%, respectively (p < 0.05). CONCLUSION CSC exerts effects on the migration of human gingival epithelial cells through the activation of the MAPK ERK1/2 and p38 signaling pathways. P. gingivalis infection attenuates the CSC-induced migration at least partly by suppressing the phosphorylation of ERK1/2 and p38, but other pathways are likely to be involved in this modulatory process.
Collapse
Affiliation(s)
- K Imamura
- Department of Periodontology, Tokyo Dental College, Tokyo, Japan
| | - E Kokubu
- Department of Microbiology, Tokyo Dental College, Tokyo, Japan
| | - D Kita
- Department of Periodontology, Tokyo Dental College, Tokyo, Japan
| | - K Ota
- Department of Periodontology, Tokyo Dental College, Tokyo, Japan
- Oral Health Science Center, Tokyo Dental College, Tokyo, Japan
| | - K Yoshikawa
- Department of Periodontology, Tokyo Dental College, Tokyo, Japan
| | - K Ishihara
- Department of Microbiology, Tokyo Dental College, Tokyo, Japan
- Oral Health Science Center, Tokyo Dental College, Tokyo, Japan
| | - A Saito
- Department of Periodontology, Tokyo Dental College, Tokyo, Japan
- Oral Health Science Center, Tokyo Dental College, Tokyo, Japan
| |
Collapse
|
45
|
Okumura T, Nakashima T, Aita M, Ochi Y, Kawahara D, Masuda H, Hioki K, Ohno Y, Saito A, Nagata Y. Verification of Mechanical and Dosimetric Accuracy for Head and Neck Volumetric Modulated Arc Therapy With Jaw Tracking. Int J Radiat Oncol Biol Phys 2016. [DOI: 10.1016/j.ijrobp.2016.06.2226] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
46
|
Nishibuchi I, Murakami Y, Takahashi I, Takeuchi Y, Saito A, Kimura T, Nishio T, Nagata Y. Salvage Radiation Therapy for Superficial Esophageal Cancer After Incomplete Endoscopic Resection. Int J Radiat Oncol Biol Phys 2016. [DOI: 10.1016/j.ijrobp.2016.06.1085] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
47
|
Kimura T, Nakashima T, Saito A, Takeuchi Y, Takahashi I, Nishibuchi I, Murakami Y, Nishio T, Nagata Y. Combined Ventilation and Perfusion Imaging Correlates With the Dosimetric Parameters of Radiation Pneumonitis in Radiation Therapy Planning for Lung Cancer. Int J Radiat Oncol Biol Phys 2016. [DOI: 10.1016/j.ijrobp.2016.06.296] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
48
|
Tanimoto H, Fukutomi Y, Yasueda H, Takeuchi Y, Saito A, Watai K, Sekiya K, Tsuburai T, Asano K, Taniguchi M, Akiyama K. Molecular-based allergy diagnosis of allergic bronchopulmonary aspergillosis in Aspergillus fumigatus-sensitized Japanese patients. Clin Exp Allergy 2016; 45:1790-800. [PMID: 26118958 DOI: 10.1111/cea.12590] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2014] [Revised: 05/11/2015] [Accepted: 06/07/2015] [Indexed: 01/10/2023]
Abstract
BACKGROUND Distinguishing between patients with allergic bronchopulmonary aspergillosis (ABPA) and Aspergillus fumigatus (Af)-sensitized asthmatic patients without ABPA is sometimes difficult owing to the IgE-cross-reactivity between Af and other fungal allergens. OBJECTIVE To establish the usefulness of molecular-based allergy diagnostics using allergen components from Af in distinguishing ABPA from Af-sensitized asthma without ABPA. METHODS Sera from Japanese patients with ABPA (n = 53) and Af-sensitized asthma without ABPA (n = 253) were studied. The levels of IgE and IgG antibodies to allergen components from Af and IgE antibodies to different fugal allergen extracts were measured by ImmunoCAP. Comorbid atopic dermatitis (AD) was taken into consideration in the sensitization profile analysis. RESULTS Patients with ABPA possessed significantly higher levels of IgE antibodies to Asp f 1, and Asp f 2 than asthmatic patients without ABPA. The areas under the receiver operating characteristic curves for the levels of IgE to Asp f 1 and Asp f 2 as diagnostic markers of ABPA were 0.75 and 0.78, respectively. The presence of IgE positivity to Asp f 1 and/or Asp f 2 resulted in increased sensitivity while losing little specificity. Comorbid AD was associated with higher levels of IgE to Asp f 6 (manganese superoxide dismutase from Af, a ubiquitous pan-allergen in fungi) and low but positive levels of IgE to other Af-components, which hampered the serological discrimination of ABPA. CONCLUSIONS AND CLINICAL RELEVANCE The levels of IgE to Asp f 1 and/or Asp f 2 can effectively differentiate ABPA from Af-sensitized asthma, suggesting that the amounts of IgE specific for these molecules are markers for genuine Af-sensitization in ABPA. However, comorbid AD must be taken into consideration in the interpretation of high IgE to Asp f 6. Establishing of IgE-sensitization profiles using panel of Af-allergen components provides valuable information for distinguishing genuine vs. cross-reactive sensitization in Af-sensitized patients.
Collapse
Affiliation(s)
- H Tanimoto
- Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Kanagawa, Japan
| | - Y Fukutomi
- Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Kanagawa, Japan
| | - H Yasueda
- Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Kanagawa, Japan
| | - Y Takeuchi
- Division of Respiratory Medicine and Clinical Allergy, Fujita Health University, Toyoake, Aichi, Japan
| | - A Saito
- Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Kanagawa, Japan
| | - K Watai
- Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Kanagawa, Japan
| | - K Sekiya
- Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Kanagawa, Japan
| | - T Tsuburai
- Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Kanagawa, Japan
| | - K Asano
- Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan
| | - M Taniguchi
- Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Kanagawa, Japan
| | - K Akiyama
- Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Kanagawa, Japan
| |
Collapse
|
49
|
Wang Q, Takashima S, Takayama F, Wang JC, Kawakami S, Saito A, Matsushita T, Sone S. Detection of occult metastatic lymph nodes in the neck with gray-scale and power doppler us. Acta Radiol 2016; 42:312-9. [PMID: 11350291 DOI: 10.1080/028418501127346701] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
Purpose: To determine the most accurate criterion for predicting malignancy of small cervical lymph nodes with gray-scale ultrasound (GSUS) and power Doppler ultrasound (PDUS). Material and Methods: Findings of 69 pathologically verified cervical nodes (38 benign, 31 malignant) in 57 patients without wide echogenic hilum on GSUS that measured less than 10 mm in minimal axial diameter were prospectively studied. Minimal and maximal axial diameters, ratios of minimal to maximal axial diameters, and presence or absence of calcification or necrosis of the nodes were assessed. On PDUS, vascularity in the node was classified into 4 pattern groups. A logistic model was used to evaluate the significant factors for predicting malignancy. Results: The logistic model revealed that the minimal axial diameter and vascularity patterns were the only significant factors for malignancy. Using the minimal axial diameter, a node larger than 8 mm showed the highest accuracy (73%) with 45% sensitivity and 93% specificity. Of the vascularity patterns, spotted or peripheral pattern had the highest accuracy (80%) with 61% sensitivity and 93% specificity. A combined criterion of the minimal axial diameter larger than 8 mm and spotted or peripheral pattern increased the accuracy to 82% and sensitivity to 77% but specificity decreased to 86%. Conclusion: A combined criterion of minimal axial diameter and vascular patterns was most accurate for diagnosing occult metastatic lymph nodes in the neck.
Collapse
Affiliation(s)
- Q Wang
- Department of Radiology, Shinshu University School of Medicine, Matsumoto, Japan
| | | | | | | | | | | | | | | |
Collapse
|
50
|
Li F, Sone S, Takashima S, Kiyono K, Yang ZG, Hasegawa M, Kawakami S, Saito A, Hanamura K, Asakura K. Effects of JPEG and wavelet compression of spiral low-dose CT images on detection of small lung cancers. Acta Radiol 2016; 42:156-60. [PMID: 11259942 DOI: 10.1080/028418501127346657] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
Purpose: To compare the effect of compression of spiral low-dose CT images by the Joint Photographic Experts Group (JPEG) and wavelet algorithms on detection of small lung cancers. Material and Methods: Low-dose spiral CT images of 104 individuals (52 with peripheral lung cancers smaller than 20 mm and 52 control subjects) were used. The original images were compressed using JPEG or wavelet algorithms at a ratio of 10:1 or 20:1. Five radiologists interpreted these images and evaluated the image quality on a high-resolution CRT monitor. Observer performance was studied by receiver operating characteristic (ROC) analysis. Results: There was no significant difference in the detection of cancers measuring 6 to 15 mm in uncompressed images and in those compressed by either of the algorithms, although the quality of images compressed at 20:1 with the wavelet algorithm was somewhat inferior. A lower diagnostic accuracy was noted using images compressed by the JPEG or wavelet algorithms at 20:1 in detecting lung cancers measuring 6 to 10 mm and cancers measuring from 6 to 15 mm with ground-glass opacity. Conclusion: Compression of low-dose CT images at a ratio of 10:1 using JPEG and wavelet algorithms does not compromise the detection rate of small lung cancers.
Collapse
Affiliation(s)
- F Li
- Department of Radiology, Shinshu University School of Medicine, Matsumoto, Japan
| | | | | | | | | | | | | | | | | | | |
Collapse
|